BMYBristol Myers Squibb Co (BMY)
Bristol Myers Squibb Co Stock (BMY) Forecast
The Bristol Myers Squibb Co (BMY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $59.74, representing a -4.38% decrease from the current price of $62.48. The highest analyst price target is $63.23, and the lowest is $56.25.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
Is Bristol Myers Squibb Co (BMY) A Buy Now?
According to our latest analysis, BMY could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 3 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on BMY, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.71 indicates that BMY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 60.89 indicates that BMY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 93.91 indicates that BMY is overbought. This suggests that BMY price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 15.60 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of 97.16 indicates that BMY is still overbought but not to an extreme extent.
Long-term BMY price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bristol Myers Squibb Co financial reports and earnings history, Bristol Myers Squibb Co (BMY) stock could reach $66.46 by 2030, $75.62 by 2040 and $96.76 by 2050. See the projected annual prices until 2050 of the Bristol Myers Squibb Co stock below:
- Bristol Myers Squibb Co (BMY) is expected to reach an average price of $65.63 in 2035, with a high prediction of $67.33 and a low estimate of $45.58. This indicates an +5.04% change from the last recorded price of $62.48.
- Bristol Myers Squibb Co (BMY) stock is projected to chart a bullish course in 2040, with an average price target of $53.31, representing an -14.67% change from its current level. The forecast ranges from a conservative $52.66 to a sky-high $75.62.
- Our analysts predict Bristol Myers Squibb Co (BMY) to change +10.47% by 2045, soaring from $68.18 to an average price of $69.02, potentially reaching $93.69. While $68.18 is the low estimate, the potential upside is significant.
- Bristol Myers Squibb Co (BMY) stock is expected to climb by 2050, reaching an average of $84.66, a +35.50% change from its current level. However, a wide range of estimates exists, with high and low targets of $96.76 and $81.23, respectively, highlighting the market's uncertainty.
Bristol Myers Squibb Co Stock (BMY) Year by Year Forecast
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2026
The predicted value for Bristol Myers Squibb Co (BMY) in 2026 is set at an average of $61.02. Estimates vary from a peak of $68.64 to a trough of $52.06, indicating an -2.34% surge from the present price of $62.48.
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bristol Myers Squibb Co (BMY) is $75.72, with a high forecast of $83.64 and a low forecast of $63.90. This indicates an +21.19% increase from the last price of $62.48.
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2028
In 2028, Bristol Myers Squibb Co (BMY) is projected to reach an average price of $70.41, with a high projection of $84.50 and a low estimate of $61.42. This indicates an +12.68% rise from the last price of $62.48.
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2029
The 2029 price forecast for Bristol Myers Squibb Co Stock (BMY) is $51.35 on average, with a high prediction of $62.37 and a low estimate of $42.46. This represents an -17.81% decrease from the previous price of $62.48.
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2030
Bristol Myers Squibb Co Stock (BMY) is expected to reach an average price of $56.46 in 2030, with a high forecast of $66.46 and a low forecast of $47.14. This signifies an -9.63% decrease from the last price of $62.48.
